New Clinical Data Highlight Effect of PARP Inhibitors on Ovarian Cancer Treatment
September 28th 2019At ESMO Congress 2019, Mansoor Raza Mirza, MD, chief oncologist at Copenhagen University Hospital, discussed the latest practice-changing clinical data results involving PARP inhibitor therapy in ovarian cancer.